Cel-Sci Corp Series S
CVM.WS
CVM.WS was delisted on the 8th of October, 2018.
0 hedge funds and large institutions have $0 invested in Cel-Sci Corp Series S in 2021 Q2 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, reducing their positions, and 1 closing their positions.
11% more call options, than puts
Call options by funds: $11.4M | Put options by funds: $10.3M
100% less funds holding
Funds holding: 1 → 0 (-1)
100% less capital invested
Capital invested by funds: $390K → $0 (-$390K)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RCM
Requisite Capital Management
Dallas,
Texas
|
-$390K |
CVM.WS Hedge Fund Activity: Q2 2021 in Review
0 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in Cel-Sci Corp Series S (CVM.WS) for Q2 2021, worth a combined $0 — down 100% from $390K a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of CVM.WS and 0 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 0 added.
The largest seller was Requisite Capital Management, exiting entirely with an estimated $390K sold.
- 0 institutional investors held Cel-Sci Corp Series S (CVM.WS) as of Q2 2021, down from 1 in Q1 2021.
- Funds reported $0 of Cel-Sci Corp Series S stock for Q2 2021, down 100% quarter-over-quarter.
- 0 funds opened new Cel-Sci Corp Series S positions in Q2 2021 and 1 closed out, a net change of -1 holder.
- The largest Cel-Sci Corp Series S seller in Q2 2021 was Requisite Capital Management, an estimated $390K sold.
Based on aggregated 13F filings for Q2 2021.